On Monday, the U.S. Supreme Court denied certiorari in Canna Provisions, Inc. et al. v. Bondi, a high-profile lawsuit that...
In cannabis cultivation today, many decisions are made in response to market pressures such as speed, yield, and potency. But...
Cannabis ETFs soared after U.S. President Donald Trump announced that he is mulling an executive order regarding the reclassification of marijuana as a less...
Prominent right-wing media figures and lawmakers alike sounded the alarm over President Donald Trump's consideration of marijuana rescheduling. Conservative alarm...
A partnership between High Times and Hoodie Analytics gives retailers and brands increased visibility on the publication’s digital platform. Cannabis...
Plant-touching cannabis companies would benefit from marijuana rescheduling, but it's one step on a longer reform road. What’s next after...
Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly...
Returning to classic strains isn't about nostalgia - it's about building a scalable cannabis market. Blue Dream’s revenge: Why the...
The number of active cannabis cultivation permits in the U.S. has dropped by 24% since 2023. Massive drop in cannabis...
PharmaCann Inc. has agreed to sell a package of its retail cannabis assets in Colorado to Vireo Growth Inc. in...